Cargando…
Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
IN BRIEF Women with type 2 diabetes are less likely to receive prescriptions for contraceptives despite the fact that diabetes is associated with an increased risk of maternal and fetal complications. In the largest case series to date examining use of the levonorgestrel-releasing intrauterine devic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053853/ https://www.ncbi.nlm.nih.gov/pubmed/30078945 http://dx.doi.org/10.2337/cd17-0028 |